I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 24% ± 7% | |
| dendritic cell | 3 studies | 20% ± 2% | |
| oligodendrocyte | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 24% ± 7% | |
| dendritic cell | 3 studies | 20% ± 2% | |
| oligodendrocyte | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 490.47 | 1445 / 1445 | 100% | 25.71 | 183 / 183 |
| intestine | 100% | 613.43 | 966 / 966 | 100% | 34.22 | 527 / 527 |
| liver | 100% | 1132.92 | 226 / 226 | 100% | 37.11 | 406 / 406 |
| ovary | 100% | 389.72 | 180 / 180 | 100% | 29.33 | 430 / 430 |
| stomach | 100% | 545.58 | 359 / 359 | 100% | 31.47 | 286 / 286 |
| breast | 100% | 596.08 | 459 / 459 | 100% | 32.18 | 1116 / 1118 |
| uterus | 100% | 422.46 | 170 / 170 | 100% | 29.87 | 458 / 459 |
| lung | 100% | 438.58 | 576 / 578 | 100% | 28.90 | 1155 / 1155 |
| bladder | 100% | 489.00 | 21 / 21 | 100% | 29.21 | 502 / 504 |
| brain | 99% | 400.72 | 2628 / 2642 | 100% | 21.96 | 705 / 705 |
| prostate | 100% | 418.98 | 245 / 245 | 99% | 25.07 | 499 / 502 |
| thymus | 100% | 475.19 | 653 / 653 | 99% | 23.04 | 601 / 605 |
| kidney | 100% | 894.89 | 89 / 89 | 99% | 25.23 | 891 / 901 |
| pancreas | 99% | 325.01 | 324 / 328 | 99% | 22.23 | 177 / 178 |
| skin | 100% | 605.00 | 1809 / 1809 | 98% | 23.27 | 463 / 472 |
| adrenal gland | 100% | 864.20 | 258 / 258 | 96% | 18.14 | 221 / 230 |
| adipose | 100% | 571.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 27.44 | 29 / 29 |
| muscle | 100% | 645.67 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 498.45 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.51 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.79 | 1 / 1 |
| blood vessel | 100% | 363.06 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 502.51 | 843 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 15.43 | 76 / 80 |
| peripheral blood | 81% | 419.36 | 748 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051560 | Biological process | mitochondrial calcium ion homeostasis |
| GO_0036444 | Biological process | calcium import into the mitochondrion |
| GO_0051204 | Biological process | protein insertion into mitochondrial membrane |
| GO_0032979 | Biological process | protein insertion into mitochondrial inner membrane from matrix |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0043022 | Molecular function | ribosome binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MAIP1 |
| Protein name | m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1) Matrix AAA peptidase interacting protein 1 |
| Synonyms | C2orf47 |
| Description | FUNCTION: Promotes sorting of SMDT1/EMRE in mitochondria by ensuring its maturation . Interacts with the transit peptide region of SMDT1/EMRE precursor protein in the mitochondrial matrix, leading to protect it against protein degradation by YME1L1, thereby ensuring SMDT1/EMRE maturation by the mitochondrial processing peptidase (PMPCA and PMPCB) . . |
| Accessions | ENST00000392290.6 ENST00000435773.2 Q8WWC4 H7C0V0 ENST00000295079.6 |
